This independent association was not attenuated after adjusting for cardiovascular biomarkers that represent systemic inflammation (hs-CRP), [80] subclinical myocardial injury (hs-cTnI), [81] or myocyte stretch (NT-proBNP), [82] and can be useful for prognosticating outcomes among patients with CAD. The gene discussed is CRP; the disease is coronary artery disorder.